Longitudinal study of immunity to SARS-CoV2 in ocrelizumab-treated MS patients up to 2 years after COVID-19 vaccination
一项关于接受奥瑞珠单抗治疗的多发性硬化症患者在接种新冠疫苗后长达两年内对SARS-CoV-2免疫力的纵向研究
期刊:Annals of Clinical and Translational Neurology
影响因子:3.9
doi:10.1002/acn3.52081
Kister, Ilya; Curtin, Ryan; Piquet, Amanda L; Borko, Tyler; Pei, Jinglan; Banbury, Barbara L; Bacon, Tamar E; Kim, Angie; Tuen, Michael; Velmurugu, Yogambigai; Nyovanie, Samantha; Selva, Sean; Samanovic, Marie I; Mulligan, Mark J; Patskovsky, Yury; Priest, Jessica; Cabatingan, Mark; Winger, Ryan C; Krogsgaard, Michelle; Silverman, Gregg J
SARS-CoV-2
新冠
神经科学
多发性硬化症
微生物学
免疫/内分泌